TUBGCP2 Antikörper (AA 2-194)
Kurzübersicht für TUBGCP2 Antikörper (AA 2-194) (ABIN1109377)
Target
Alle TUBGCP2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 2-194
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human, Porcine, Mouse, Rat
-
Aufreinigung
- Protein-A affinity chromatography
-
Reinheit
- > 95 % pure by SDS-PAGE
-
Immunogen
- GST-fusion protein containing amino acids 2-194 of mouse GCP2
-
Isotyp
- IgG2b
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- Phosphate buffered saline (PBS), approx. pH 7.4, 15 mM sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- TUBGCP2 (Tubulin, gamma Complex Associated Protein 2 (TUBGCP2))
-
Andere Bezeichnung
- TUBGCP2
-
Hintergrund
- Gamma tubulin complex component 2 (GCP2) is 95-103 kDa protein which associates with two molecules of gamma tubulin and one molecule of gamma tubulin complex component 3 (GCP3), to form the gamma tubulin small complexes (gammaTuSCs). These complexes interact with GCP4, 5, and 6 to form the gamma tubulin ring complexes (gammaTuRCs), which are embedded in the microtubule organizing center matrix where they nucleate microtubules. The gammaTuRCs are also involved in the regulation of microtubule plus and minus end dynamics. Components of gamma tubulin complexes are highly conservative in eukaryotes.Synonyms: GCP-2, GCP2, Gamma-ring complex protein 103 kDa, Gamma-tubulin complex component 2, Grip103, Spc97, Spindle pole body protein Spc97 homolog
-
Gen-ID
- 10844
-
NCBI Accession
- NP_006650
-
UniProt
- Q9BSJ2
-
Pathways
- M Phase, SARS-CoV-2 Protein Interaktom
Target
-